Buy Isosorbide Mononitrate 30 mg Online in India | Steris Healthcare
For people searching for Isosorbide Mononitrate 30 mg tablets online in India, it is important to verify the exact strength, formulation, manufacturer or marketer, batch number, expiry date, and prescription requirements before purchasing. The medicine should not be started, stopped, or adjusted independently.
Why Isosorbide Mononitrate 30 mg is Important
Angina can occur when the heart muscle does not receive enough oxygen-rich blood to meet its requirements, commonly because of narrowed coronary arteries. Isosorbide mononitrate belongs to the organic nitrate group and helps prevent angina by producing vasodilation.
By relaxing blood vessels, the medicine can reduce the amount of work the heart has to perform. This can help decrease the likelihood of angina occurring during activities that previously triggered symptoms. Official prescribing information identifies extended-release isosorbide mononitrate as a medicine for the prevention of angina due to coronary artery disease.
An important distinction for patients is that oral extended-release isosorbide mononitrate is not sufficiently rapid-acting to stop an acute angina attack. Patients with coronary artery disease should follow the emergency or rescue-medication plan provided by their doctor for sudden chest pain.
Key Benefits
The potential benefits of Isosorbide Mononitrate 30 mg are primarily related to long-term prevention and management of angina.
It may:
Help prevent episodes of angina associated with coronary artery disease.
Reduce cardiac workload through vasodilation.
Help improve exercise tolerance in appropriately selected patients.
Provide sustained nitrate activity when prescribed as an extended-release formulation.
Form part of an individualized cardiovascular treatment plan.
The medicine should not be viewed as a cure for coronary artery disease. It manages symptoms and helps prevent angina as part of a broader treatment strategy that may include other medicines, lifestyle measures, and cardiovascular risk-factor management.
What are the benefits of Isosorbide Mononitrate 30 mg?
CARDULES ISMN SR30 may be prescribed when a healthcare professional determines that nitrate therapy is appropriate for preventing recurrent angina symptoms.
Its extended-release design allows the medicine to provide its effects over an extended period rather than being used as an immediate rescue treatment. Clinical information for extended-release isosorbide mononitrate demonstrates effects on exercise tolerance in patients with chronic stable angina, although response can vary between individuals and may decrease with continued exposure because of nitrate tolerance.
Patients should continue taking other prescribed cardiovascular medicines unless their doctor advises otherwise.
Side Effects
Like other nitrate medicines, Isosorbide Mononitrate 30 mg can cause side effects. Some effects are related to its blood-vessel-relaxing action and may be more noticeable when treatment is started or the dose is changed.
Possible side effects may include:
Headache
Dizziness
Light-headedness
Weakness
Flushing
Nausea
Low blood pressure
Increased heart rate
Feeling faint, particularly when standing
Headache is a commonly recognized effect of nitrate therapy. Dizziness or light-headedness may occur because blood pressure can fall after taking the medicine.
Patients should stand up slowly, particularly when beginning treatment, and should tell their healthcare professional if dizziness or fainting becomes significant.
Available Substitute
There are other nitrate medicines and different brands containing isosorbide mononitrate, but they should not automatically be considered interchangeable.
A substitute can differ in:
Strength
Immediate-release or extended-release formulation
Dosing schedule
Manufacturer
Excipients
Administration instructions
Another nitrate, such as isosorbide dinitrate, is also not necessarily a direct replacement because it has different pharmacokinetic and dosing characteristics.
If CARDULES ISMN SR30 is unavailable, ask a doctor or pharmacist to identify an appropriate alternative based on the exact prescription.
Dosage Guidelines for Isosorbide Mononitrate 30 mg
The dosage of Isosorbide Mononitrate 30 mg should be determined by the prescribing healthcare professional according to the patient's cardiovascular condition, response to treatment, other medicines, blood pressure, and formulation.
For certain extended-release isosorbide mononitrate products, prescribing information lists 30 mg once daily as a recommended starting dose, with subsequent adjustment when clinically appropriate. The exact instructions for CARDULES ISMN SR30 should be followed rather than automatically applying dosing information from another manufacturer's formulation.
Extended-release tablets are generally swallowed whole and should not be crushed or chewed when the product is designed for extended release. Some product labeling specifies morning administration. Always follow the instructions supplied with the prescribed product.
How to Use
CARDULES ISMN SR30 should be taken orally according to the prescription.
When using the medicine:
Swallow the extended-release tablet as directed.
Do not crush or chew an extended-release tablet unless the product information specifically allows it.
Take the medicine consistently according to the prescribed schedule.
Do not stop treatment suddenly without discussing it with your doctor.
Do not use it as a substitute for emergency treatment of sudden severe chest pain.
If you experience significant dizziness, fainting, or unusual chest symptoms, contact a healthcare professional promptly.
Precautions & Warnings
Before using Isosorbide Mononitrate 30 mg, tell your doctor if you have low blood pressure, dehydration, heart problems, or any previous reaction to nitrate medicines.
One of the most important precautions concerns medicines used for erectile dysfunction. Sildenafil, tadalafil, vardenafil, and related phosphodiesterase-5 inhibitors can interact dangerously with nitrates and cause severe hypotension, fainting, or myocardial ischemia.
Isosorbide mononitrate should also not be combined with riociguat, because the combination can cause significant hypotension.
Patients who are taking blood-pressure medicines or other vasodilators should inform their doctor because combined effects can increase the risk of low blood pressure.
Alcohol may also increase dizziness or blood-pressure-lowering effects in some patients.
Older adults and people who are volume-depleted may be more susceptible to orthostatic hypotension and should use nitrate therapy under appropriate medical supervision.
Mechanism of Action
Isosorbide mononitrate is an organic nitrate and a vasodilator with effects on both arteries and veins.
After administration, isosorbide mononitrate contributes to the formation of nitric oxide-related signaling that activates the soluble guanylate cyclase–cyclic GMP pathway in vascular smooth muscle. This promotes relaxation of vascular smooth muscle.
The resulting vasodilation, particularly venodilation, reduces venous return to the heart. This can decrease cardiac preload and reduce the amount of oxygen the heart requires. Arterial dilation can also reduce vascular resistance and cardiac workload.
Through these effects, isosorbide mononitrate helps reduce the likelihood of myocardial oxygen imbalance that can contribute to angina.
Because its effects are not rapidly reversible, extended-release oral isosorbide mononitrate is intended for prevention rather than rapid termination of an acute angina episode.
Conclusion
Isosorbide Mononitrate 30 mg, marketed as CARDULES ISMN SR30 by Steris Healthcare, is a nitrate medicine used primarily for the prevention of angina associated with coronary artery disease. Its vasodilatory action helps reduce cardiac workload and the heart's oxygen demand.
The medicine should be taken exactly as prescribed, particularly because incorrect use can cause significant low blood pressure, dizziness, fainting, or other cardiovascular complications. Importantly, extended-release oral isosorbide mononitrate is not intended to provide rapid relief during an acute angina attack.
Comments
Post a Comment